These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8448545)

  • 1. National Marrow Donor Program: progress and challenges.
    Champlin R; Coppo P; Howe C
    Bone Marrow Transplant; 1993; 11 Suppl 1():41-4. PubMed ID: 8448545
    [No Abstract]   [Full Text] [Related]  

  • 2. The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation.
    Ballen KK; King RJ; Chitphakdithai P; Bolan CD; Agura E; Hartzman RJ; Kernan NA
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):2-7. PubMed ID: 18721774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program.
    Miller JP; Perry EH; Price TH; Bolan CD; Karanes C; Boyd TM; Chitphakdithai P; King RJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):29-36. PubMed ID: 18721778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unrelated bone marrow transplantation in Canada, the national experience. Canadian Red Cross Society.
    Buskard NA; Warren P
    Bone Marrow Transplant; 1993; 11 Suppl 1():45-8. PubMed ID: 8448546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worldwide Web of bone marrow donors.
    Weinberger BB; Lerchie S; Strong-Erickson K
    J La State Med Soc; 1997 Dec; 149(12):490-2. PubMed ID: 9425860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor registries for bone marrow transplantation. Technology Assessment Meeting Statement, May 13-15, 1985. National Institutes of Health.
    Int J Technol Assess Health Care; 1985; 1(3):729-38. PubMed ID: 10300790
    [No Abstract]   [Full Text] [Related]  

  • 7. Allogeneic bone marrow transplantation using unrelated marrow donors.
    Fay JW; Collins RH; Piñeiro L
    Bone Marrow Transplant; 1993; 11 Suppl 1():81-2. PubMed ID: 8448557
    [No Abstract]   [Full Text] [Related]  

  • 8. The National Marrow Donor Program in 2006: constants and challenges.
    Atlas LD
    Transfusion; 2006 Jul; 46(7):1080-4. PubMed ID: 16836552
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry.
    Spellman S; Setterholm M; Maiers M; Noreen H; Oudshoorn M; Fernandez-Viña M; Petersdorf E; Bray R; Hartzman RJ; Ng J; Hurley CK
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):37-44. PubMed ID: 18721779
    [No Abstract]   [Full Text] [Related]  

  • 10. The National Marrow Donor Program: improving access to hematopoietic stem cell transplantation.
    Dodson KL; Coppo PA; Confer DL
    Clin Transpl; 1999; ():121-7. PubMed ID: 11038630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The National Marrow Donor Program with emphasis on the early years.
    McCullough J; Perkins HA; Hansen J
    Transfusion; 2006 Jul; 46(7):1248-55. PubMed ID: 16836575
    [No Abstract]   [Full Text] [Related]  

  • 12. Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program.
    MacMillan ML; Davies SM; Nelson GO; Chitphakdithai P; Confer DL; King RJ; Kernan NA
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):16-22. PubMed ID: 18721776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The National Marrow Donor Program with emphasis on the early years.
    Fisher BS
    Transfusion; 2007 Jun; 47(6):1101-2; author reply 1102. PubMed ID: 17524105
    [No Abstract]   [Full Text] [Related]  

  • 14. Representation of Hispanics in the National Marrow Donor Program.
    Freytes CO; Beatty PG
    Bone Marrow Transplant; 1996 Mar; 17(3):323-7. PubMed ID: 8704681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donation activities and product integrity in unrelated donor allogeneic hematopoietic transplantation: experience of the National Marrow Donor Program.
    Bolan CD; Hartzman RJ; Perry EH; Trainor L; Miller J; Miller R; Hanley L; Chitphakdithai P; King RJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):23-8. PubMed ID: 18721777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program.
    Karanes C; Nelson GO; Chitphakdithai P; Agura E; Ballen KK; Bolan CD; Porter DL; Uberti JP; King RJ; Confer DL
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):8-15. PubMed ID: 18721775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The origins and development of the National Marrow Donor Program.
    Zumwalt ER; Howe CW
    Leukemia; 1993 Jul; 7(7):1122. PubMed ID: 8321042
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathway to a cure. Common vision, teamwork achieve successful blood stem cell transplant.
    Arp D
    Healthplan; 2003; 44(2):30-3. PubMed ID: 12675006
    [No Abstract]   [Full Text] [Related]  

  • 19. National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants.
    Hurley CK; Baxter Lowe LA; Logan B; Karanes C; Anasetti C; Weisdorf D; Confer DL
    Biol Blood Marrow Transplant; 2003 Oct; 9(10):610-5. PubMed ID: 14569557
    [No Abstract]   [Full Text] [Related]  

  • 20. The National Marrow Donor Program.
    Walker T
    Minn Med; 1999 Jun; 82(6):26-8. PubMed ID: 10389454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.